We are very happy to be a partner of the 3rd ADC Process Development Summit 2025 of Boston, organized by Hanson Wade, where BSP will be an Innovation Partner
The 3rd ADC Process Development Summit is the industry’s one-stop shop for optimizing process development for ADCs through refining conjugation yield, reducing impurities and improving purification, and efficiently scaling-up processes.
We will be present to stay up to date and benchmark our processes against industry standards, for technical and strategic discussion to help us who live and breathe optimizing their ADC manufacturing processes.
The biopharma industry is continuing to prioritize innovative technologies like site-specific conjugation to advance the next wave of ADCs with enhanced properties and homogeneous design. For this reason, it is crucial to develop robust, reproducible, cost-effective, and streamlined ADC manufacturing processes to ensure your product quality can be demonstrated to regulators.
During this event will be present experts in bioconjugation, purification, regulatory CMC, drug substance, and drug product for 3 days of technical presentations and discussions, with over 80 attendees set to be in the room from biopharma, alongside service providers with process development and purification expertise.
Save the Date!!! Next Wednesday, 22nd of October, Laura Santinelli, will present its speech "FROM IND TO THE LONG TERM COMMERCIAL SUPPLY: a step ahead against the challenges of the bioconjugates" during the Scientific Program Day 1, from 11:15 AM.
BSP's team looks forward to meeting You at our booth in the Exhibitors Area. To request a meeting, please send an e-mail to Business.Development@Bsppharmaceuticals.com
